MedTrace Logo

A Study of Vedolizumab in Adults With Crohn's Disease (CD)

NCT05192863 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 72

Last updated 2025-11-13

No results posted yet for this study

Summary

The main aim of this study is to see if adults with CD treated with vedolizumab have less symptoms and inflammation of the bowel assessed by ultrasonography.

Participants will be treated with vedolizumab according to their clinic's standard practice.

Conditions

Interventions

OTHER

No Intervention

This is a non-interventional study.

Sponsors & Collaborators

Principal Investigators

  • Study Director · Takeda

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-20
Primary Completion
2025-10-31
Completion
2025-10-31
FDA Drug
Yes

Countries

  • Canada
  • Israel
  • Italy

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05192863 on ClinicalTrials.gov